When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Geovax Labs Stock Forecast

OTCMKTS:GOVX BUY

$2.25 (-11.76%)

Volume: 5.93M

Closed: Aug 16, 2022

Hollow Logo Score: 0.853

Geovax Labs Stock Forecast

BUY OTCMKTS:GOVX
$2.25 (-11.76%)

Volume: 5.93M

Closed: Aug 16, 2022

Score Hollow Logo 0.853
Which way will GOVX go? Request
Tue, Aug 16, 2022 Hold/Accumulate
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSI min/max Values: [ 25 - 80 ] RSI14 is 54 and the stock is currently not being overbought or oversold
Last Reaction
Be the first to comment on GOVX

Volatile ride for Geovax Labs stock price on Tuesday moving between $2.20 and $2.54
(Updated on Aug 16, 2022)


Buy or Hold candidate since 2022-07-25 Gain 41.51% PDF

The Geovax Labs stock price fell by -11.76% on the last day (Tuesday, 16th Aug 2022) from $2.55 to $2.25. During the last trading day the stock fluctuated 15.40% from a day low at $2.20 to a day high of $2.54. The price has fallen in 8 of the last 10 days and is down by -26.47% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 6 million shares were bought and sold for approximately $13.34 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 34.4% during the next 3 months and, with a 90% probability hold a price between $1.24 and $5.49 at the end of this 3-month period.

Signals & Forecast

The Geovax Labs stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $2.64. On a fall, the stock will find some support from the long-term average at approximately $1.67. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, August 01, 2022, and so far it has fallen -42.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $1.99 and $1.80. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Geovax Labs finds support just below today's level at $1.99. If this is broken, then the next support from accumulated volume will be at $1.80 and $1.70.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.34 between high and low, or 15.40%. For the last week, the stock has had a daily average volatility of 14.39%.

Our recommended stop-loss: $2.12 (-5.92%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday 17th we expect Geovax Labs Inc to open at $2.33, and during day (based on 14 day Average True Range), to move between $1.73 and $2.77, which gives a possible trading interval of +/-$0.52 (+/-23.26%) up or down from last closing price. If Geovax Labs Inc takes out the full calculated possible swing range there will be an estimated 46.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.29 (1.78%) than the support at $1.99 (11.56%), our systems don't find the trading risk/reward intra-day attractive and any bets should be hold until the stock is closer to the support level.

Is Geovax Labs Inc stock A Buy?

Geovax Labs holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.853

Hold/Accumulate Unchanged

Predicted Opening Price for Geovax Labs Inc of Wednesday, August 17, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price August 17, 2022 Current price
$2.33 $2.25 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 2.67 18.59 %
2.54 12.84 %
2.46 9.29 %
Current price: 2.25
Support 2.20 -2.21 %
2.12 -5.77 %
1.99 -11.52 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.73 21.33 %
2.32 3.11 %
2.29 1.78 %
Current price 2.25
Support 1.99 -11.56%
1.80 -20.00%
1.70 -24.44%

Click to get the best stock tips daily for free!

About Geovax Labs Inc

Geovax Labs GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, ch... Read more

.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT